GSK to Cut Jobs Amid £1.9bn Cost-Cutting and R&D Investment Plan

pharmaceuticals

28 July 2026 at 11:28 pm

GSK to Cut Jobs Amid £1.9bn Cost-Cutting and R&D Investment Plan

HyperFast News

Summary

GSK is set to cut jobs as part of a £1.9bn cost-cutting plan, which will fund a £400m investment in UK life sciences and a new R&D center in Cambridge. The pharmaceutical company will move over 1,000 scientists to its new Cambridge site and close its Stevenage R&D facility by 2029.

Select what you want to create

Turn this story into an image post, carousel, video, audio reel, blog, and more — all from HyperFast News.

FAQ

Newsroom FAQs

About the public HyperFast News news feed powered by NewsEngine.